日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

VAMP7-dependent late endosomal secretion of ER and mitochondrial proteins impacts the tumor microenvironment and macrophage engagement.

VAMP7 依赖的内质网和线粒体蛋白的晚期内体分泌会影响肿瘤微环境和巨噬细胞的参与。

Vats Somya, Dionisio Pedro, Lemercier Quentin, Pineau Raphael, Therreau Ludivine, Lipecka Joanna, Cholley Béatrice, Moog Jean-Baptiste, Wojnacki Jose, Keime Céline, Zala Diana, Bun Philippe, Freire Sofia, Domingues Neuza, Danglot Lydia, Guerrera Ida Chiara, Delevoye Cédric, Chevet Eric, Raimundo Nuno, Galli Thierry

Hemophagocytic Macrophages in the Peripheral Blood of a Critically Ill Patient With COVID-19 and RSV Infection

新冠肺炎和呼吸道合胞病毒感染重症患者外周血中的噬血细胞性巨噬细胞

Zala, Ashik; Sadek, Ahmed; Elsaid, Ahmed; Patel, Ketan C; Ramia De Cap, Maximiliano; Bain, Barbara J

TRPML1 suppresses pulmonary fibrosis by limiting collagen and elastin deposition.

TRPML1 通过限制胶原蛋白和弹性蛋白的沉积来抑制肺纤维化。

Weiden Eva-Maria, Serianz Zala, Klingl Yvonne, Jörs Simone, Jaślan Dawid, Keller Marco, Castro Sandra Prat, Mkhitaryan Mane, Jeridi Aicha, Briukhovetska Daria, Spix Barbara, Scotto Rosato Anna, Agami Ahmed, Schiller Herbert B, Rajan Suhasini, Schredelseker Johann, Fois Giorgio, Frick Manfred, Kobold Sebastian, Klein Margarethe, Geisler Fabian, Garcia-Fortanet Jorge, Murphy Leon O, Bracher Franz, Wahl-Schott Christian, Gudermann Thomas, Dietrich Alexander, Biel Martin, Yildirim Ali Önder, Grimm Christian

Long-term sequelae and functional outcomes in the largest cohort of Nipah virus survivors in Bangladesh

孟加拉国最大规模的尼帕病毒幸存者队列的长期后遗症和功能结局

Aquib, Wasik Rahman; Mondal, Utpal K; Nazneen, Arifa; Rahman, Dewan Imtiaz; Choudhury, Shadman Sakib; Sarkar, Tonmoy; Sarker, Smita; Shafique, S M Zafor; Islam, Ariful; Bablu, Arifur Rahman; Alam, Muhammad Rashedul; Abdulla, Faruq; Islam, Nazrul; Hossain, Md Kamal; Siddika, Ayesha; Clark, Carolyn; Zala, Vijay; Cherian, Neil; Amin Chowdhury, Kamal Ibne; Sultana, Sharmin; Klena, John D; Rahman, Mohammed Ziaur; Rahman, Mustafizur; Luby, Stephen P; Montgomery, Joel M; Shirin, Tahmina; Banu, Sayera; Satter, Syed Moinuddin

Systemic immune dysregulation in hypertensive disorders of pregnancy persists years after delivery

妊娠期高血压疾病引起的全身免疫失调在分娩后仍持续数年。

Sabayev, Maximilian; Ganio, Edward A; Stelzer, Ina A; Sato, Masaki; Cambriel, Amélie; Bonham, Thomas A; Juvan, Zala N; Diop, Maïgane; Iyer, Purnima; Sedan, Oshra; Aghaeepour, Nima; Angst, Martin S; Shaw, Gary M; Stevenson, David K; Stefanick, Marcia L; Boyd, Heather A; Melbye, Mads; Hlatky, Mark A; Winn, Virginia D; Gaudilliere, Brice; Feyaerts, Dorien

Fatty Acid Composition and Aromatic Profile of Krškopolje and Modern Pig Breeds Reared Under Organic and Conventional Systems

有机和常规饲养条件下克尔什科波列猪和现代猪品种的脂肪酸组成和香气特征

Mencin, Marjeta; Babič, Katja; Strojnik, Lidija; Sel, Zala; Kastelic, Andrej; Ogrinc, Nives

The involvement of Th17 inflammation and miR-363-3p in airway epithelial barrier dysfunction

Th17炎症和miR-363-3p参与气道上皮屏障功能障碍

Lässer, Cecilia; Ax, Elisabeth; Weidner, Julie; Winslow, Sofia; Ingelhag, Hannes; Calvén, Jenny; Malmhäll, Carina; Jevnikar, Zala; Olsson, Henric; Rådinger, Madeleine

Adherence and Metabolic Outcomes of Early and Late Time-Restricted Eating with Energy Restriction vs. Energy Restriction Alone: A 6-Month Follow-Up

早期和晚期限时饮食联合能量限制与单纯能量限制的依从性和代谢结果:一项为期 6 个月的随访研究

Črešnovar, Tanja; Habe, Bernarda; Mohorko, Nina; Kenig, Saša; Jenko Pražnikar, Zala; Petelin, Ana

Directed C-H activation of 13α-estrone: a pathway to promising AKR1C inhibitors via docking and biological studies

定向CH活化13α-雌酮:通过分子对接和生物学研究探索有前景的AKR1C抑制剂的途径

Mernyák, Erzsébet; Gjorgoška, Marija; Sinreih, Masa; Kotnik, Aljaž; Zanoškar, Zala; Godec, Ajda; Jukič, Marko; Bren, Urban; Ignácz, Rebeka; Szőri, Kornél; Kele, Zoltán; Hunyadi, Attila; Rižner, Tea Lanišnik

Phase 2a randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of londamocitinib (AZD4604) two times per day for 12 weeks in adult patients with moderate-to-severe asthma uncontrolled on medium-high-dose ICS-LABA

一项 IIa 期随机、双盲、安慰剂对照研究,旨在评估 londamocitinib (AZD4604) 每日两次,持续 12 周,治疗中高剂量吸入性糖皮质激素-长效β2受体激动剂 (ICS-LABA) 控制不佳的中重度哮喘成人患者的疗效和安全性。

Mustapa, Mohd Nubli; Hughes, Rod; Jensen, Tina J; Dosanjh, Davinder P; Konstantinidis, Kyriakos V; Jonsson, Julia; Nemes, Szilárd; Jevnikar, Zala; Jones, Michael; Adams, Amanda; Belvisi, Maria G; Akuthota, Praveen; Kocks, Janwillem W H